CIK 0001641281 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Bolt Biotherapeutics, Inc.
Sign in to watch- Ticker
- BOLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472804636
- Phone
- 650-665-9295
- Business address
- 900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Bolt Therapeutics, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Senior VP, Finance and PAO bought 125 shares at $5.49 ($687)
- 4 Grant or award Chief Operating Officer acquired 30,000 shares (grant or award)
- 4 Open-market buy President, CEO and CFO bought 125 shares at $5.49 ($687)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Senior VP, Finance and PAO bought 5,000 shares at an average $0.57 ($2,835)
- 4 Open-market buy President, CEO and CFO bought 5,000 shares at an average $0.57 ($2,835)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 8 · 142 filings